Immune responses in cardiac repair and regeneration: a comparative point of view
- 1.4k Downloads
Immediately after cardiac injury, the immune system plays major roles in repair and regeneration as it becomes involved in a number of processes including damage-associated signaling, inflammation, revascularization, cardiomyocyte dedifferentiation and replenishment, and fibrotic scar formation/resolution. Recent studies have revealed that different immune responses occur in the various experimental models capable or incapable of cardiac regeneration, and that harnessing these immune responses might improve cardiac repair. In light of this concept, this review analyzes current knowledge about the immune responses to cardiac injury from a comparative perspective. Insights gained from such comparative analyses may provide ways to modulate the immune response as a potential therapeutic strategy for cardiac disease.
KeywordsMyocardial infarction Macrophages Neutrophils Scar formation Scar resolution Neonatal mice Salamander Zebrafish Medaka Comparative analysis
Heart failure is a major cause of morbidity and mortality, in part because of the inability of the human heart to replenish lost muscle tissue from cardiomyopathies including myocardial infarction (MI). Instead, fibrotic scar forms during the repair process, compromises cardiac function, and eventually leads to adverse remodeling and failure. Interestingly, recent studies have reported that adult cardiac muscle cells (cardiomyocytes, CMs) retain some capacity to divide in both mice [7, 21, 44, 64, 92, 94, 108, 131, 125] and humans [5, 6, 77], thus raising the possibility of promoting endogenous cardiac regeneration in patients.
Regenerative and non-regenerative models provide opportunities for comparative analyses to gain knowledge regarding cardiac regeneration, as well as to develop new therapeutic strategies for human cardiac disease [17, 99, 104]. Interestingly, comparative studies between neonatal and adult mice [3, 59], and between phylogenetically related species such as zebrafish (Danio Rerio) and medaka (Oryzias latipes)  have suggested that the capacity for regeneration does not solely rely on genetic makeup, environmental conditions (e.g., hypoxia), or evolutionary complexity; instead, the type and extent of the immune responses to cardiac injury seem to be a major difference between these regenerative and non-regenerative models [3, 58, 59], and may largely influence the recovery post experimental MI, as well as clinical prognosis [30, 96].
With respect to animal models, general capacity for tissue regeneration seems to inversely correlate with evolutionary complexity across the animal kingdom [124, 137]. Unlike mammals, some vertebrates are capable of endogenous heart regeneration in adulthood, including certain fish and amphibians . Zebrafish are a favored model as they exhibit a remarkable regenerative capacity after various cardiac insults [12, 35, 95, 106, 139]. Recently, another fresh water teleost, medaka (Oryzias latipes), has been reported to lack revascularization and CM proliferation after cardiac injury, subsequently displaying excessive fibrosis and an unresolved scar . Direct comparison between zebrafish and medaka represents a unique platform to identify and investigate mechanisms underlying cardiac regeneration . Another recent study reported differential regenerative capacity in Mexican cavefish (Astyanax mexicanus) living in surface dwellings versus those living in caves, and revealed a complex interplay between CM proliferation and scar resolution . QTL analysis further revealed 3 loci modulating heart regeneration in cavefish and modern genomic and genetic approaches should lead to their identification in the near future.
In terms of the mammalian models, newborn mice retain a certain level of regenerative capacity in response to cardiac injury [40, 93, 115]. Despite this regenerative capacity, variable amounts of residual fibrotic tissues remain in neonatal hearts after recovery, depending on the injury model used and the extent of injury [55, 107]. This regenerative capacity is mostly lost by 7 days after birth, and adult mice exhibit minimal CM replenishment, unresolved scars and contractile dysfunction after cardiac injury [40, 93, 115]. Comparative studies between neonatal and adult mice have already been very informative [3, 59, 73], and they are like to remain a powerful approach.
Inflammatory signaling and cellular contribution
The immune response post MI can be temporally divided into the pro-inflammatory phase and the inflammatory resolution/reparative phase, involving components of both the innate and adaptive immune systems. Inflammation after cardiac injury is mainly triggered by molecules released from necrotic cells and it is programmed to be resolved when the cell debris is cleared. This process takes place in both regenerative and non-regenerative models, yet profound differences can be observed which lead to scar resolution and tissue replenishment in the former, and scar maturation and tissue remodeling in the latter. These differences are due at least in part from the differential response of cardiac resident cells and recruited immune cells in regenerative versus non-regenerative models. Of note, prolonged and unresolved inflammation seems to enhance the fibrotic response and worsen functional recovery during the recovery phase . This review tries to distill our current understanding of the roles of the immune response during cardiac repair with a focus on inflammation. We also discuss the differential immune response in regenerative versus non-regenerative models, as well as potential strategies to modulate the immune response to improve cardiac recovery.
After MI, tissue damage rapidly triggers the response of the immune system. Immune cells are initially recruited to the injured tissue, clear debris and dead cells, and degrade the extracellular matrix . Later, programmed resolution of inflammation allows the recruitment and activation of myofibroblasts for extracellular matrix (ECM) deposition and vascular cells to stabilize the new vessels . Inflammation is both essential and deleterious for cardiac repair and regeneration, depending on its precise spatial and temporal regulation. Inflammation is required for cardiac regeneration post injury [3, 45, 58, 59]. In addition, acute inflammation initiates a reparative response in neonatal mouse hearts  and can precondition the heart for effective regeneration in zebrafish . On the other hand, studies in mice suggest that inflammation extends tissue damage post MI, while minimizing inflammation reduces the infarct size and adverse remodeling [2, 86, 120]). In light of the importance and complexity of the inflammatory response, we discuss in detail the tight regulation of inflammation initiation and resolution during cardiac healing.
Triggers of inflammation: DAMPs, complements, reactive oxygen species (ROS) and TLR signaling
High-mobility group B1 (HMGB1) is the best characterized MI-induced DAMP. In the mouse MI model, HMGB1 is an important chromatin-binding protein released by necrotic cells and/or secreted by macrophages . HMGB1 promotes the maturation and migration of immune cells by interacting with PRRs, such as TLR2/4 and RAGE [54, 111]. Upon release or secretion, HMGB1 facilitates tissue repair and healing by promoting the switch of macrophages to a tissue-healing phenotype, the activation and proliferation of stem cells, and neoangiogenesis . In addition, HMGB proteins also function as universal sentinels for nucleic acid-mediated innate immune responses. Extracellular DNA and RNA released by necrotic cells bind to macrophage TLRs and activate the secretion of pro-inflammatory cytokines, including IL-6, IL-12, and Tumor Necrosis Factor alpha (TNFα) [48, 134]. Released nucleic acids play dual roles upon cardiac insult. On the one hand, extracellular RNA released during both I/R injury and MI promotes myocardial inflammation and reducing serum RNA levels by RNase administration conferred cardiac protection against I/R injury [15, 63]. Conversely, extracellular DNA activates TLR9 signaling and promotes the proliferation and differentiation of cardiac fibroblasts into myofibroblasts. Myofibroblasts in turn promote ECM deposition and prevent cardiac rupture after MI in mice . Interestingly, administration of the TLR9 agonist CpG-ODN prior to I/R injury induced preconditioning and attenuated myocardial injury via upregulation of the anti-inflammatory cytokine IL-10 [11, 66]. Furthermore, administration of the TLR3 agonist poly I:C after cardiac injury promoted regeneration in the non-regenerative medaka . The roles of TLR signaling in cardiac healing will be discussed in detail in a later section.
The ECM provides mechanical support and maintains the structural integrity of the heart. During the inflammatory phase of MI in mice, high matrix metalloproteinase (MMP) activity from necrotic cells, neutrophils and macrophages degrades the cardiac ECM. The resulting ECM fragments play active roles in inflammatory propagation/modulation, signal transduction and mechanical remodeling during cardiac repair [25, 31, 129]. Interestingly, a common transition from the early fibrin-enriched ECM environment to the late collagen-based mature scar occurs after cardiac injury in both regenerative and non-regenerative models [31, 35]. The transient fibrin-based ECM modulates inflammation by regulating leukocyte engagement via integrin receptors, influencing immune cell behavior, and stimulating macrophage chemokine secretion through TLRs [18, 27, 112]. It may also serve as a scaffold for migrating inflammatory cells and as a support for proliferating endothelial cells and fibroblasts . Accordingly with their critical roles, ECM synthesis genes are amongst the most upregulated ones post injury in both the neonatal mouse heart  and the zebrafish heart [58, 61, 71]. The ECM components fibronectin and tenascin-C are essential for cell cycle re-entry and proliferation of CMs during zebrafish and newt heart regeneration [71, 127]. Subsequently, the mature collagen-based scar resolves without causing adverse remodeling in regenerative models [35, 93]. The cellular and molecular mechanisms of scar resolution are still unknown. From a comparative perspective, it may be extremely valuable to determine the potential differences in ECM composition and dynamic changes in regenerative and non-regenerative models, and further investigate how the ECM potentially modulates cardiac healing. As a recent example, AGRIN was identified as a cardiac ECM component enriched in neonatal compared to adult mice, and it is required for the full reparative capacity in neonates . Moreover, a single administration of AGRIN could promote regenerative capacity in adult mice after MI .
The complement system
The complement system is another critical component of innate immunity, and it functions as the first defense to eliminate pathogens by marking them for phagocytosis or directly lysing them via the assembly of the membrane attack complex [13, 100]. In addition, the complement system triggers inflammation via C3a and C5a fragments (anaphylatoxins) [13, 100]. These fragments facilitate neutrophil recruitment through activation of the endothelium to increase vessel permeability and leukocyte adhesion [13, 100]. Moreover, C3a and C5a fragments might induce fibrotic repair after MI by facilitating and modulating cardiac pluripotent/progenitor cell (CPC) differentiation towards fibroblasts/myofibroblasts. On the other hand, the complement system is also involved in tissue repair and regeneration [100, 116]. In the heart, the complement receptor gene C5aR1 is activated in CMs and endothelial cells after cardiac resection in regenerative models including axolotl, zebrafish and neonatal mice . Inhibition of C5aR1 significantly attenuated the activation of CM proliferation in all three species, suggesting that C5aR1 mediates an evolutionarily conserved response to cardiac injury . Of note, differences in macrophage infiltration of the injured zone between C5aR1 WT and knockout mice were observed, despite the fact that C5aR1 expression was not colocalized with macrophage markers . These findings suggest a role for C5aR1 in non-myeloid cells during cardiac regeneration, but the detailed mechanisms remain unclear. Clearly, a lot more work needs to be done on the complement system to understand its role in modulating the immune response and other aspects of the regenerative process.
Reactive oxygen species (ROS)
ROS have been implicated as the cue to promote immune cell infiltration into sites of injury [78, 83]. ROS released from mitochondria of necrotic cells or secreted by neutrophils trigger the inflammatory response through direct activation of the inflammasome in cardiac resident cells including fibroblasts  and mast cells . Inflammasome activation leads to the maturation and secretion of the pro-inflammatory cytokines Interleukin 1β (IL-1β) and Interleukin 18 (IL-18) .
Excessive generation of ROS during reperfusion induces inflammation and extended myocardial injury . Consistently, ROS production in the mouse heart during the first week of birth causes DNA damage and cell cycle arrest in CMs, and may account for the decreased regenerative capacity in adults . Furthermore, chronic hypoxia minimizes ROS production and induces CM proliferation following MI, resulting in significant recovery of left ventricle (LV) systolic function [53, 81]. These findings support the hypothesis that reduction in ROS and oxidative DNA damage favors CM cycling.
Besides their harmful role when present at high levels during early reperfusion, minimal ROS levels during ischaemia and/or at reperfusion are critical for the redox signaling of cardioprotection, which reduces the extent of infarct . In the context of regeneration, hydrogen peroxide, a major ROS, initiates inflammation by rapid recruitment of leukocytes to the wound in zebrafish , and promotes CM proliferation and cardiac repair . Nevertheless, how redox signaling is balanced during heart regeneration and if it can be better modulated in non-regenerative models remain elusive. These findings underscore the importance of redox signaling during cardiac healing and call for further investigation.
As the most prominent members of PRRs, TLRs belong to a family of transmembrane receptors responding to various DAMPs, resulting in the activation of pro-inflammatory cytokine and chemokine genes . Functional studies indicate that TLRs are important mediators of the post-infarction inflammatory reaction, whereby the loss of function of some TLRs seems to be beneficial for cardiac healing after MI [2, 86, 120].
Despite a general acknowledgment of their role in triggering inflammatory responses, a detailed understanding of TLR signaling in cardiac regeneration remains elusive. TLR signaling seems to trigger CM proliferation during regeneration. Administration of zymosan or lipopolysaccharides (LPS), TLR2 and TLR4 agonists, respectively, preconditions CMs for cell cycle re-entry in zebrafish , and induced CM proliferation in the neonatal mouse heart . In zebrafish, LPS administration also triggers the expression of the retinoic acid synthesizing enzyme Aldh1a2, which has been shown to be required for CM proliferation during heart regeneration . Furthermore, in non-regenerative medaka, IP injection of the TLR3 agonist poly I:C promotes macrophage recruitment, revascularization, and CM proliferation . Altogether, these data suggest that although damage signals appear to trigger inflammation and lead to extended infarction in adult mammalian MI models, differential responsiveness of TLR signaling to particular stimuli might induce protection or regeneration. To better understand how differential TLR responsiveness modulates cardiac healing, thorough examination of transcriptomic and cytokine responses upon various TLR ligand stimulation should be performed in both regenerative and non-regenerative models. The detailed function of each TLR should also be determined to reveal the mechanisms of preconditioning and how each TLR contributes to the overall inflammatory response post cardiac injury.
Cellular components involved in inflammation
Damage signals trigger inflammation in both resident cells (including endothelial cells, fibroblasts, mast cells, tissue resident macrophages, CMs, and epicardial cells), as well as in recruited cells (including neutrophils, monocyte-derived macrophages, lymphocytes, and dendritic cells). The outcome following cardiac injury appears to depend largely on the number, kinetics, and phenotypes of these cells. Amongst them, innate immune cells, including monocytes, macrophages and neutrophils, have more established functions in clearing cell debris, propagating and resolving inflammation, and even promoting tissue restoration by secreting growth factors and remodeling the ECM . On the other hand, the contribution of adaptive immune cells in cardiac repair and regeneration is slowly being revealed. For example, B cells are associated with autoimmunity against healthy CMs after cardiac injury , while T cells play versatile roles in autoreactivity, inflammation modulation and tuning macrophage polarity [122, 128, 141]. Undoubtedly, the question of cell-specific contributions to the overall injury response still requires extensive investigation. Here, we summarize information on a set of resident and recruited cells with more defined roles in modulating inflammatory response post cardiac injury.
Cardiac resident cells
As the most abundant cardiac resident cells, endothelial cells constitute > 60% of the non-myocytes in the mouse and zebrafish hearts [88, 90]. Endothelial activation is required for leukocyte extravasation during inflammation. For example, upon activation by DAMPs, P-selectin is significantly upregulated in endothelial cells allowing neutrophil adhesion and infiltration after I/R injury . In addition to adhesive interactions, activated endothelial cells secrete cytokines and chemokines, including the monocyte chemoattractant protein-1 (MCP-1) to attract monocytes to the injured myocardium . The roles of endothelial cells in immunity have recently been reviewed.
Fibroblasts constitute the second largest population of cardiac resident cells in mouse, and they are usually quiescent and enmeshed in the interstitial tissue and perivascular matrix. Upon severe ischemia, interstitial fibroblasts serve as sentinels to detect myocardial injury and trigger inflammation . DAMP-PRRs activation on fibroblasts leads to altered cellular function including changes in proliferation and migration, transdifferentiation into myofibroblasts, ECM turnover, and production of fibrotic and inflammatory paracrine factors . In addition to DAMPs, ROS also stimulate inflammasome activation and IL-1b production in cardiac fibroblasts . During this pro-inflammatory phase, cardiac fibroblasts are activated by DAMPs and ROS, and are maintained by IL-1 signaling. Later in the resolution/reparative phase, when the wound has been cleared by phagocytic cells and inflammation has been resolved, these fibroblasts transdifferentiate into myofibroblasts with a matrix synthetic function . In non-regenerative models, cardiac repair following sudden loss of a large number of cardiomyocytes is dependent on the clearance of dead cells and the formation of a collagen-based scar to maintain structural integrity . The active termination and the finely tuned fibrotic response of fibroblasts are, thus, critical to minimize hypertrophic remodeling and organ failure.
However, it remains unclear how fibroblasts contribute to heart regeneration, especially during scar resolution. Collagenous scar formation and maturation occur in regenerative models just as in non-regenerative models. However, scar resolution occurs only in regenerative models and it is dependent on fibroblast function. In salamanders, alternative activation of fibroblasts after macrophage depletion resulted in a permanent, highly cross-linked ECM scar and compromised heart regeneration. Similarly in zebrafish, fibroblasts appear to be required for scar resolution, as ablating col1a2-expressing fibroblasts impaired CM proliferation and scar resolution . These data illustrate the critical and dynamic roles of fibroblasts in propagating inflammation and promoting scar formation and resolution during post infarct healing. Our understanding of the contribution, regulation and alternative activation of fibroblasts, as well as how fibroblasts interact with immune cells clearly requires more detailed studies.
On the contrary, after MI in neonatal mice, the population of embryonic-derived resident macrophages which generates minimal inflammation expands and helps to mediate cardiac recovery by promoting angiogenesis and CM proliferation (Fig. 4) . In neonatal mice, depletion of phagocytes (presumably resident macrophages) by clodronate liposomes compromised angiogenesis and regeneration . Similarly, in zebrafish, depletion of macrophages by clodronate liposomes before cryoinjury led to defects in revascularization and CM proliferation at 7 dpci, despite the presence of macrophages (Fig. 3). These defects could be due to the loss of tissue-resident macrophages or a shift in macrophage polarity, which will be further discussed in the monocyte and macrophage section below.
Recruited inflammatory cells
Neutrophils are rapidly recruited to injured tissues by DAMPs, cytokines and chemokines, activated complements, and histamine [70, 113]. They dominate the infarcted myocardium in the first 2 days post MI in adult mice , as well as post cardiac injury in zebrafish . Corresponding to their well-established anti-pathogen function, neutrophils clear cell debris in the infarct, produce inflammatory cytokines, and accelerate monocyte influx . Due to their pro-inflammatory and cytotoxic properties, excessive neutrophil activity has been associated with poor prognosis, remodeling and mortality after MI [1, 72].
In line with previous findings in adult mice, excess and prolonged neutrophil activity is largely associated with an unresolved inflammatory response, and potentially affects cardiac repair and regeneration. Ly6G+ neutrophil numbers recruited to the injured myocardium are reduced in neonatal mice compared to adults, which may lead to decreased pro-inflammatory cytokine production and decreased collateral tissue damage from neutrophil activity (Fig. 4) [3, 59]. In adult mice, insufficient removal of neutrophils resulting from decreased macrophage recruitment post MI leads to enhanced matrix degradation, delayed collagen deposition and increased susceptibility to cardiac rupture . Comparative analyses of zebrafish and medaka revealed that neutrophil clearance after cardiac injury is delayed in the latter (Fig. 3). Similarly, neutrophil retention was associated with an excessive fibrotic response and unresolved scar upon macrophage depletion by clodronate liposomes in zebrafish (Fig. 3) .
On the beneficial side, neutrophils play an active role in the resolution of inflammation by secreting myeloperoxidase, which dampens the hydrogen peroxide burst after tissue wounding . In addition, neutrophils orchestrate post-MI healing by polarizing macrophages towards a reparative phenotype . Furthermore, neutrophils promote angiogenesis during inflammation by secreting VEGF , and their arrival in the injured area precedes the initiation of revascularization during zebrafish heart regeneration . These findings suggest that therapeutic strategies to reduce acute inflammation driven by neutrophils after MI should be carefully considered as they might interfere with the healing response modulated by neutrophils including revascularization, macrophage polarization and resolution of inflammation. The potential roles played by neutrophils immediately after cardiac injury are particularly interesting and beg for further investigation in both regenerative and non-regenerative models.
Mononuclear phagocytes–monocytes and macrophages
Monocytes are a type of leukocytes which can differentiate into macrophages and dendritic cells. Monocyte-derived macrophages scavenge dead CMs, degrade their released macromolecules, and promote ECM remodeling and blood vessel formation . Monocytes and monocyte-derived macrophages are functionally heterogenous . Distinct Ly6Chi and Ly6Clow monocyte subsets are sequentially recruited to injured hearts. Ly6Chi monocytes peak during the early pro-inflammatory phase and exhibit phagocytic, proteolytic, and inflammatory functions, while Ly6Clow monocytes come later in the resolution phase, exhibit attenuated inflammatory properties, and express VEGF . Differentially polarized M1- and M2-like macrophages are involved in biphasic repair processes (pro-inflammatory and resolution/repair phases) post MI [80, 110, 133]. In adult mice, CD206+F4/80+CD11b+ M2-like macrophages predominantly populate the infarct area and exhibit strong reparative abilities after MI, while their depletion resulted in a worsened prognosis and frequent cardiac rupture . This phenomenon was due at least in part to impaired fibroblast activation and reduced collagen fibril formation . In addition, this decreased tissue repair could be rescued by an external supply of M2-like macrophages, or an increase in M2-like macrophages by IL-4 administration . Interestingly, M2 macrophages in the reparative phase of infarcted hearts seem to be derived from Ly6Chi monocytes and proliferate locally to affect inflammation resolution and wound healing . These data support the requirement of both Ly6Chi and Ly6Clow monocyte subsets, and the beneficial effect of promoting M2 macrophage polarization during cardiac repair in adult mice.
The importance of macrophage polarization in heart regeneration has also been shown in zebrafish. Delayed macrophage recruitment by clodronate liposome pre-depletion compromised heart regeneration, despite control-like macrophage numbers in clodronate-treated hearts at 7 dpci (Fig. 3) . Correspondingly, macrophage recruitment was also found to be delayed and significantly reduced in non-regenerative medaka post cardiac injury, and the kinetics and function of macrophage could be restored by poly I:C injections (Fig. 3) . These findings indicate that macrophage polarization shifts during the regenerative response and the underlying mechanisms remain to be elucidated. As mentioned earlier, M2-like resident macrophages dominate in the neonatal mouse heart post MI and are essential for cardiac regeneration (Fig. 4) . Together, these data support a role for macrophage polarization in modulating the inflammatory response and promoting heart regeneration.
Of note, the M1/M2 paradigm was initially based on the distinct function/phenotype of macrophage populations induced by a selected set of ligands . Thus, the M1/M2 paradigm might be too simplistic in the context of tissue injury, as macrophages might constitute a broad spectrum of mixed phenotypes, an issue which requires significant further study . The interactions between infiltrated macrophages and the complex and dynamic microenvironment of the cardiac infarct, the kinetics of macrophage polarization, and the potential macrophage phenotypes/functions await further investigation. Temporally coordinated differentiation of monocyte-derived M1 and M2 macrophages by distinct cytokines, DAMPs and other signaling molecules might accelerate cardiac healing and possibly even promote regeneration.
Circulating lymphocytes comprise both B and T cells, which are the major cellular components of adaptive immunity. T cells are divided into CD8+ and CD4+ subsets: CD8+ T cells directly lyse target cells, while CD4+ T cells secrete various cytokines and orchestrate the immune response. Depending on their cytokine repertoire, CD4+ T cells are further classified as Th1 (IFN-γ, IL-2 and TNFα), Th2 (IL-4, IL-5, IL-13), Th17 (IL-17, IL-21, and IL-22) and regulatory T cells (Tregs) (TGF-β, IL-35). The significance of lymphocyte activation by autoantigens such as α-MHC released by the infarcted myocardium has only begun to be unraveled . CD4+ T cell depleted mice, but not those lacking CD8+ T cells, exhibited significantly smaller infarcts than WT mice after I/R injury [135, 136]. Similarly, depletion of mature B lymphocytes impeded monocyte mobilization, limited myocardial injury and improved heart function post MI .
Among CD4+ T cells, Foxp3+CD25+ Tregs play a critical role in myocardial healing. Tregs enhance the recovery of damaged tissues by suppressing the immune response, promoting revascularization, and modulating monocyte/macrophage differentiation toward the M2 phenotype (Fig. 2) [128, 141]. In adult mice, expansion of Tregs by adoptive transfer or a CD28 superagonistic antibody attenuated the post-infarction inflammatory response, protecting the heart from adverse remodeling after MI [69, 118]. Clinical use of statin to decrease cholesterol levels after acute MI has also been shown to modulate the immune response by enhancing regulatory T-cell numbers and inhibiting pro-inflammatory T-cell subpopulations . These lines of evidence suggest that Tregs are potent modulators of the immune response, which can limit and resolve inflammation, as well as attenuate ventricular remodeling, thereby improving cardiac function after MI.
It has been proposed that the mature and complex adaptive immune system in adult mammals compared to neonates and other evolutionarily more ancient animals (such as amphibians and fish) might be responsible for their limited regenerative capacity . Consistently, immunomodulation aiming to restore cardiac tolerance was proposed to tune down adaptive immunity and accelerate regenerative therapies . Comparison of CD4+ T cells in neonatal and adult mice revealed that T cells from neonates have an intrinsic “default” mechanism to become Tregs in response to T-cell receptor (TCR) stimulations, and that this ability gradually diminishes within the first 2 weeks after birth (Fig. 4) . In line with this observation, the human fetal immune system generates more Tregs that suppress immune responses, especially autoantigen-specific immunity . As first shown in zebrafish, Tregs are essential for heart regeneration (Fig. 3). Foxp3+ Treg-like cells (zTregs) home to damaged cardiac tissue starting from 3 days post injury and promote CM proliferation through the secretion of the CM mitogen Neuregulin . Conditional ablation of zTregs impaired CM proliferation and heart regeneration . In mouse, Tregs have been reported to promote CM proliferation during pregnancy, in both maternal and fetal hearts, as well as after MI in adults . In addition, Tregs are indispensable for heart regeneration in neonatal mice, potentially by promoting monocyte/macrophage recruitment as well as CM proliferation (Fig. 4)  (a preprint article on biorxiv without peer-review). These data support an active role of Tregs in cardiac regeneration through immune modulation and the secretion of Neuregulin . As promoting Treg function in cardiac repair may be therapeutically valuable, it will be important to reach a mechanistic understanding of this response.
Resolution of inflammation
Timely resolution and containment of inflammation are critical for cardiac healing. Conversely, a prolonged inflammatory response leads to increased CM loss, cardiac remodeling, extensive fibrotic response, and even cardiac rupture . From a comparative point of view, it is often speculated that the inflammatory response in non-regenerative models is excessive and prolonged after cardiac injury . However, the precise spatial and temporal regulation of the inflammatory response toward scar-free regeneration after MI remains unclear. Compiling evidence puts macrophage function and polarization at center stage. Functionally heterogeneous M1 and M2 macrophages dominate the injured mouse heart at earlier (M1, 1-3 days) and later (M2, after 5 days) stages. Pro-inflammatory M1 macrophages express high level of pro-inflammatory cytokines, such as TNFα, IL-1 and IL-6; while reparative M2 macrophages express high level of anti-inflammatory cytokine IL-10, in addition to pro-inflammatory cytokines . For a summary of macrophage phenotypes and their respective markers (mostly cytokines and chemokines) in mice, please see Kain et al. .
There have been several strategies proposed to inhibit post-MI inflammation, but early attempts have often resulted in adverse outcomes in clinical trials [38, 85]. On the other hand, approaches that focus on resolving post-MI inflammation have been sparsely used . As an example, administration of the pro-resolving lipid mediator Resolving D in mice accelerated the inflammation resolution following MI and improved LV function . Consistently, faster inflammatory resolution occurred after reperfusion, and coincided with increased inflammatory cell recruitment, accelerated revascularization, improved LV function and reduced remodeling . These data suggest that facilitating active resolution may prevent persistent inflammation and heart failure. Strategies aiming to modulate inflammation sometimes lead to the opposite outcome (e.g., adverse remodeling vs. cardiac preconditioning/protection). This phenomenon is of great interest and worthy of systematic investigation to gain mechanistic insights. One hypothesis is that improved revascularization post reperfusion accelerates debris clearance, immune cell recruitment, turnover, and function, as well as inflammatory resolution, in a situation more similar to that in regenerative models (despite still not optimal enough for regeneration). Immune stimulation in a permanent MI model might achieve similar effects of an accelerated immune response and preconditioning/cardiac protection, but the same treatment might lead to over stimulation and/or unresolved inflammation in an I/R model. Of note, in both the comparisons between I/R injury and MI, as well as between zebrafish and medaka, an acute and robust immune response is associated with better functional outcome and is compatible with heart regeneration.
Despite growing interest in the field, previous clinical trials that modulate inflammation after cardiac injury have been largely unsuccessful, partly due to the biphasic aspect of inflammation (lack of temporal control), as well as the general cytokines/immunosuppressors adopted (lack of specificity). Based on recent findings on the differential immune response between regenerative and non-regenerative models, modulating cellular processes exerting biphasic functions, including macrophage polarization and T-cell activation into Tregs, may represent a promising direction to promote cardiac healing and even regeneration. Understanding the potential interactions between immune cells (e.g., macrophages and Tregs) and between immune and non-immune cells (e.g., macrophages and fibroblasts) also requires more extensive studies (Fig. 2). In addition, the pleiotropic roles of TLR signaling represent another interesting aspect to explore in the context of MI, since activation of some TLR members seem to mediate immune modulation and preconditioning rather than conventional inflammation. In addition to the neonatal mouse model, where information directly relevant to regeneration is often mixed with the physiological changes of development, growth, and maturation , more information may be gained from non-mammalian models to further deepen our understanding of the permissive and instructive processes leading to heart regeneration. Clearly, complementary information from various models will greatly accelerate the understanding of endogenous regeneration and provide hints towards the development of effective therapies.
Open access funding provided by Max Planck Society. We thank Sven Reischauer, Arica Beisaw, Aosa Kamezaki, Anabela Bensimon Brito, João Cardeira da Silva, Srinivas Allanki, and Srinath Ramkumar for critical comments on the manuscript. We thank Mr. Tsung-Hung Hung from the Medical Art Room/IBMS for the art work. We apologize to our colleagues whose papers we could not cite due to space limitations. Research in the Stainier lab is supported in part by funds from the Max Planck Society, EU (ERC), DFG and Leducq Foundation. Research in the Lai lab is supported by funds from the Academia Sinica.
- 1.Akpek M, Kaya MG, Lam YY, Sahin O, Elcik D, Celik T, Ergin A, Gibson CM (2012) Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol 110:621–627CrossRefPubMedGoogle Scholar
- 2.Arslan F, Smeets MB, O’Neill LA, Keogh B, McGuirk P, Timmers L, Tersteeg C, Hoefer IE, Doevendans PA, Pasterkamp G, de Kleijn DP (2010) Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation 121:80–90CrossRefPubMedGoogle Scholar
- 4.Bassat E, Mutlak YE, Genzelinakh A, Shadrin IY, Umansky KB, Yifa O, Kain D, Rajchman D, Leach J, Bassat DR, Udi Y, Sarig R, Sagi I, Martin JF, Bursac N, Cohen S, Tzahor E (2017) The extracellular matrix protein agrin promotes heart regeneration in mice. Nature 547:179–184CrossRefPubMedPubMedCentralGoogle Scholar
- 21.D’Uva G, Aharonov A, Lauriola M, Kain D, Yahalom-Ronen Y, Carvalho S, Weisinger K, Bassat E, Rajchman D, Yifa O, Lysenko M, Konfino T, Hegesh J, Brenner O, Neeman M, Yarden Y, Leor J, Sarig R, Harvey RP, Tzahor E (2015) ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation. Nat Cell Biol 17:627–638CrossRefPubMedGoogle Scholar
- 24.Epelman S, Lavine KJ, Beaudin AE, Sojka DK, Carrero JA, Calderon B, Brija T, Gautier EL, Ivanov S, Satpathy AT, Schilling JD, Schwendener R, Sergin I, Razani B, Forsberg EC, Yokoyama WM, Unanue ER, Colonna M, Randolph GJ, Mann DL (2014) Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 40:91–104CrossRefPubMedPubMedCentralGoogle Scholar
- 41.Hilgendorf I, Gerhardt LM, Tan TC, Winter C, Holderried TA, Chousterman BG, Iwamoto Y, Liao R, Zirlik A, Scherer-Crosbie M, Hedrick CC, Libby P, Nahrendorf M, Weissleder R, Swirski FK (2014) Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium. Circ Res 114:1611–1622CrossRefPubMedPubMedCentralGoogle Scholar
- 49.Kain V, Ingle KA, Colas RA, Dalli J, Prabhu SD, Serhan CN, Joshi M, Halade GV (2015) Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function. J Mol Cell Cardiol 84:24–35CrossRefPubMedPubMedCentralGoogle Scholar
- 51.Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, Morimoto H, Izawa A, Takahashi Y, Masumoto J, Koyama J, Hongo M, Noda T, Nakayama J, Sagara J, Taniguchi S, Ikeda U (2011) Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 123:594–604CrossRefPubMedGoogle Scholar
- 57.Kumar AG, Ballantyne CM, Michael LH, Kukielka GL, Youker KA, Lindsey ML, Hawkins HK, Birdsall HH, Mackay CR, Larosa GJ, Rossen RD, Smith CW, Entman ML (1997) Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation 95:693–700CrossRefPubMedGoogle Scholar
- 62.Lorchner H, Poling J, Gajawada P, Hou Y, Polyakova V, Kostin S, Adrian-Segarra JM, Boettger T, Wietelmann A, Warnecke H, Richter M, Kubin T, Braun T (2015) Myocardial healing requires Reg3[beta]-dependent accumulation of macrophages in the ischemic heart. Nat Med 21:353–362CrossRefPubMedGoogle Scholar
- 66.Markowski P, Boehm O, Goelz L, Haesner AL, Ehrentraut H, Bauerfeld K, Tran N, Zacharowski K, Weisheit C, Langhoff P, Schwederski M, Hilbert T, Klaschik S, Hoeft A, Baumgarten G, Meyer R, Knuefermann P (2013) Pre-conditioning with synthetic CpG-oligonucleotides attenuates myocardial ischemia/reperfusion injury via IL-10 up-regulation. Basic Res Cardiol 108:376CrossRefPubMedPubMedCentralGoogle Scholar
- 67.Martinez FO, Gordon S (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Reports, 6, 13Google Scholar
- 74.Molawi K, Wolf Y, Kandalla PK, Favret J, Hagemeyer N, Frenzel K, Pinto AR, Klapproth K, Henri S, Malissen B, Rodewald HR, Rosenthal NA, Bajenoff M, Prinz M, Jung S, Sieweke MH (2014) Progressive replacement of embryo-derived cardiac macrophages with age. J Exp Med 211:2151–2158CrossRefPubMedPubMedCentralGoogle Scholar
- 81.Nakada Y, Canseco DC, Thet S, Abdisalaam S, Asaithamby A, Santos CX, Shah AM, Zhang H, Faber JE, Kinter MT, Szweda LI, Xing C, Hu Z, Deberardinis RJ, Schiattarella G, Hill JA, Oz O, Lu Z, Zhang CC, Kimura W, Sadek HA (2017) Hypoxia induces heart regeneration in adult mice. Nature 541:222–227CrossRefPubMedGoogle Scholar
- 82.Natarajan N, Abbas Y, Bryant DM, Gonzalez-Rosa JM, Sharpe M, Uygur A, Cocco-Delgado LH, Ho NN, Gerard NP, Gerard CJ, Macrae CA, Burns CE, Burns CG, Whited JL, Lee RT (2018) Complement receptor C5aR1 plays an evolutionarily conserved role in successful cardiac regeneration. Circulation 137:2152–2165CrossRefPubMedGoogle Scholar
- 85.Ong SB, Hernandez-resendiz S, Crespo-avilan GE, Mukhametshina RT, Kwek XY, Cabrera-fuentes HA, Hausenloy DJ (2018) Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther 186:73–87CrossRefPubMedPubMedCentralGoogle Scholar
- 87.Pase L, Layton JE, Wittmann C, Ellett F, Nowell CJ, Reyes-Aldasoro CC, Varma S, Rogers KL, Hall CJ, Keightley MC, Crosier PS, Grabher C, Heath JK, Renshaw SA, Lieschke GJ (2012) Neutrophil-delivered myeloperoxidase dampens the hydrogen peroxide burst after tissue wounding in zebrafish. Curr Biol 22:1818–1824CrossRefPubMedGoogle Scholar
- 92.Polizzotti BD, Ganapathy B, Walsh S, Choudhury S, Ammanamanchi N, Bennett DG, dos Remedios CG, Haubner BJ, Penninger JM, Kuhn B (2015) Neuregulin stimulation of cardiomyocyte regeneration in mice and human myocardium reveals a therapeutic window. Sci Transl Med 7:281ra45CrossRefPubMedPubMedCentralGoogle Scholar
- 97.Puente BN, Kimura W, Muralidhar SA, Moon J, Amatruda JF, Phelps KL, Grinsfelder D, Rothermel BA, Chen R, Garcia JA, Santos CX, Thet S, Mori E, Kinter MT, Rindler PM, Zacchigna S, Mukherjee S, Chen DJ, Mahmoud AI, Giacca M, Rabinovitch PS, Aroumougame A, Shah AM, Szweda LI, Sadek HA (2014) The oxygen-rich postnatal environment induces cardiomyocyte cell-cycle arrest through DNA damage response. Cell 157:565–579CrossRefPubMedPubMedCentralGoogle Scholar
- 120.Timmers L, Sluijter JP, van Keulen JK, Hoefer IE, Nederhoff MG, Goumans MJ, Doevendans PA, van Echteld CJ, Joles JA, Quax PH, Piek JJ, Pasterkamp G, de Kleijn DP (2008) Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res 102:257–264CrossRefPubMedGoogle Scholar
- 122.van der Borght K, Scott CL, Nindl V, Bouch¢ A, Martens L, Sichien D, van Moorleghem J, Vanheerswynghels M, de Prijck S, Saeys Y, Ludewig B, Gillebert T, Guilliams M, Carmeliet P, Lambrecht BN (2017) Myocardial infarction primes autoreactive T cells through activation of dendritic cells. Cell Rep 18:3005–3017CrossRefPubMedPubMedCentralGoogle Scholar
- 134.Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, Negishi H, Nakasato M, Lu Y, Hangai S, Koshiba R, Savitsky D, Ronfani L, Akira S, Bianchi ME, Honda K, Tamura T, Kodama T, Taniguchi T (2009) HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462:99–103CrossRefPubMedGoogle Scholar
- 138.Zacchigna S, Martinelli V, Moimas S, Colliva A, Anzini M, Nordio A, Costa A, Rehman M, Vodret S, Pierro C, Colussi G, Zentilin L, Gutierrez MI, Dirkx E, Long C, Sinagra G, Klatzmann D, Giacca M (2018) Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction. Nat Commun 9:2432CrossRefPubMedPubMedCentralGoogle Scholar
- 140.Zouggari Y, Ait-Oufella H, Bonnin P, Simon T, Sage AP, Guerin C, Vilar J, Caligiuri G, Tsiantoulas D, Laurans L, Dumeau E, Kotti S, Bruneval P, Charo IF, Binder CJ, Danchin N, Tedgui A, Tedder TF, Silvestre JS, Mallat Z (2013) B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med 19:1273–1280CrossRefPubMedPubMedCentralGoogle Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.